Duke Pathology’s Elizabeth N. Pavlisko, MD, Victor L. Roggli, MD, and the University of Pittsburgh’s Tim D. Oury, MD, PhD, who was formerly at Duke, are primary editors of Mesothelioma in the 21st Century: From Asbestos Exposure to Precision Medicine, which will be submitted to Springer in September 2027 for publishing. A number of Duke Pathology faculty members and trainees contributed content. In addition, there are several authors who were formerly at Duke.
“Dr. Pavlisko and I are very excited about this project, which involves state-of-the-art information concerning this relatively rare malignancy,” said Roggli.
The book highlights the latest approaches to diagnosing mesothelioma, including improved imaging and the latest immunohistochemical stains that help confirm the disease. It also reviews what we currently know about causes, including the changing role of asbestos exposure. The authors explain key biological processes involved in how mesothelioma develops, including how cells change over time and the immune system’s role. Finally, it outlines current treatment options and what they mean for patient outcomes.
Duke-affiliated authors contributed to the following sections:
Part 1, General Considerations:
- Chapter 3: “Experimental Animal Studies and Pathogenetic Mechanisms,” Tim D. Oury (formerly at Duke, now a professor in the Division of Molecular Genomic Pathology at the University of Pittsburgh). Other authors: Timothy N. Perkins, Nadine Oury, Brian Cunniff.
- Chapter 4: “Molecular Features,” Assistant Professor Jadee Neff, MD, PhD, and Associate Professor Carolyn Glass, MD.
- Chapter 6: “Radiological Features,” J. David Godwin, MD (formerly at Duke, now a professor of Radiology at the University of Washington).
- Chapter 7: “Cytopathology and Mesothelioma,” Assistant Professor Jeffrey Arnold, Cytopathology Fellow Jordan Burr, DO.
- Chapter 8: “Role of Fiber Analysis,” Professor Victor L. Roggli, MD, Assistant Professor Huihua Li, MD, PhD, and Anupama Kohli Sharma (formerly at Duke, now a pathology specialist practicing in Pittsburgh, PA).
Part 2, Specific Entities:
- Chapter 9: “Pleural Mesothelioma,” Professor Elizabeth Pavlisko, MD.
- Chapter 10: “Peritoneal Mesothelioma,” Sergio Pina-Oviedo, MD, (formerly at Duke, now practicing in Houston, TX).
- Chapter 12: “Mesothelioma of the Tunica Vaginalis Testis,” Kelly Butnor (formerly at Duke, now a professor at Larner College of Medicine in Vermont).
- Chapter 14: “Well Differentiated Papillary Mesothelial Tumor,” Huihua Li, MD, PhD.
- Chapter 15: “Mesothelioma in Patients with Other Neoplasia,” First-Year Resident Jacob Christofi, MD, MSc, and Assistant Professor Jadee Neff, MD, PhD.
- Chapter 16: “Treatment and Prognosis,” Professor of Surgery David Harpole Jr., MD, (Secondary appointment in Pathology), and Vignesh Raman, MD, MHS, (adjunct assistant professor in Duke Department of Surgery).
More information coming next year!